|Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study|
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
|Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease|
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of Neurology 69 (10), 1318-1325, 2012
|Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions|
VL Villemagne, V Doré, SC Burnham, CL Masters, CC Rowe
Nature Reviews Neurology 14 (4), 225-236, 2018
|Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing|
BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ...
Molecular psychiatry 18 (8), 875-881, 2013
|Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a …|
SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ...
The Lancet Neurology 15 (10), 1044-1053, 2016
|Intense physical activity is associated with cognitive performance in the elderly|
BM Brown, JJ Peiffer, HR Sohrabi, A Mondal, VB Gupta, SR Rainey-Smith, ...
Translational psychiatry 2 (11), e191-e191, 2012
|Aβ-amyloid and tau imaging in dementia|
VL Villemagne, V Dore, P Bourgeat, SC Burnham, S Laws, O Salvado, ...
Seminars in nuclear medicine 47 (1), 75-88, 2017
|A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study|
SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ...
Molecular psychiatry 19 (4), 519-526, 2014
|Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohorts|
RF Buckley, EC Mormino, RE Amariglio, MJ Properzi, JS Rabin, YY Lim, ...
Alzheimer's & Dementia 14 (9), 1193-1203, 2018
|Blood-based molecular biomarkers for Alzheimer’s disease|
H Zetterberg, SC Burnham
Molecular brain 12 (1), 1-7, 2019
|Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies|
RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ...
Journal of Alzheimer's Disease 62 (3), 965-992, 2018
|Influence of BDNF Val66Met on the relationship between physical activity and brain volume|
BM Brown, P Bourgeat, JJ Peiffer, S Burnham, SM Laws, ...
Neurology 83 (15), 1345-1352, 2014
|Association of β-amyloid and apolipoprotein E ε4 with memory decline in preclinical Alzheimer disease|
YY Lim, P Kalinowski, RH Pietrzak, SM Laws, SC Burnham, D Ames, ...
JAMA neurology 75 (4), 488-494, 2018
|Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults|
SM Laws, S Gaskin, A Woodfield, V Srikanth, D Bruce, PE Fraser, T Porter, ...
Scientific reports 7 (1), 1-11, 2017
|Blood protein markers of neocortical amyloid-β burden: a candidate study using SOMAscan technology|
N Voyle, D Baker, SC Burnham, A Covin, Z Zhang, DP Sangurdekar, ...
Journal of Alzheimer's Disease 46 (4), 947-961, 2015
|The feasibility of at-home iPad cognitive testing for use in clinical trials|
DM Rentz, M Dekhtyar, J Sherman, S Burnham, D Blacker, SL Aghjayan, ...
The journal of prevention of Alzheimer's disease 3 (1), 8, 2016
|Decreased serum zinc is an effect of ageing and not Alzheimer's disease|
A Rembach, DJ Hare, JD Doecke, SC Burnham, I Volitakis, CJ Fowler, ...
Metallomics 6 (7), 1216-1219, 2014
|En attendant centiloid|
VL Villemagne, V Doré, P Yates, B Brown, R Mulligan, P Bourgeat, ...
Science Domain International, 2014
|Predicting Alzheimer disease from a blood-based biomarker profile: a 54-month follow-up|
SC Burnham, CC Rowe, D Baker, AI Bush, JD Doecke, NG Faux, ...
Neurology 87 (11), 1093-1101, 2016
|Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden|
A Rembach, AD Watt, WJ Wilson, VL Villemagne, SC Burnham, KA Ellis, ...
Journal of Alzheimer's Disease 40 (1), 95-104, 2014